Research & Development
Product development is a critical component of our growth, and excellent science is our key point of difference.
Our capability in the field of research and development is a key enabler to Apotex being suitably positioned to develop a robust portfolio of new products. In some cases, our R&D potential enables us to circumvent patents and litigate to bring generic products to market sooner. This pioneering competence is what sets Apotex apart.
Apotex currently has over 300 new products under development, and we are investing CAD$2 billion over the next 10 years in research and development.